Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1036 (29 April), doi:10.1136/bmj.332.7548.1036-b
| The first 150 words of the full text of this article appear below. |
EDITORLet us hope that the cogent arguments advanced by Rothwell in support of more and better clinical research in the United Kingdom begin a serious dialogue that will correct the asymmetries in research funding, kudos, and leadership that have developed over the past 5-10 years.1 Rothwell's arguments apply with even greater force to the need for a clinical research effort in primary care and in health services research on topics such as the natural history of common diseases; the value of interventions, both therapeutic and preventive; and critically, as Rothwell points out, the difficulties of individualising risk and benefit in a single patient on the basis of large scale trials.
In addition to the clinical research networks described in the new NHS research and development strategy, adequate project and programme funding must be made available to support the research that Rothwell identifies. This includes follow-up studies of large
Roger Jones, Wolfson professor of general practice
King's College London School of Medicine, London SE11 6SP roger.jones@kcl.ac.uk